Cours Imprimis Pharmaceuticals Inc Nasdaq
Actions
US45323A2015
Produits pharmaceutiques
CA 2024 * | 185 M 168 M | CA 2025 * | 251 M 228 M | Capitalisation | 376 M 342 M |
---|---|---|---|---|---|
Résultat net 2024 * | -12 M -10,9 M | Résultat net 2025 * | 23 M 20,9 M | VE / CA 2024 * | 2,04 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 1,5 x |
PER 2024 * |
-33
x | PER 2025 * |
17,9
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 85,42% |
Dernier transcript sur Imprimis Pharmaceuticals Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 01/01/06 |
Andrew Boll
DFI | Director of Finance/CFO | 41 | 01/12/11 |
Jamie Webb
IRC | Investor Relations Contact | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 01/01/06 |
Director/Board Member | 65 | 26/01 | |
Adrienne Graves
BRD | Director/Board Member | 69 | 26/01 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,68% | 681 Md | |
+25,07% | 556 Md | |
-4,35% | 361 Md | |
+17,65% | 325 Md | |
+3,77% | 285 Md | |
+14,68% | 235 Md | |
+4,71% | 199 Md | |
-12,43% | 189 Md | |
-3,79% | 157 Md |